Australia markets close in 2 hours 55 minutes

Nephros, Inc. (NEPH)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.29000.0000 (0.00%)
At close: 04:00PM EST
2.3800 +0.09 (+3.93%)
After hours: 04:48PM EST

Nephros, Inc.

380 Lackawanna Place
South Orange, NJ 07079
United States
201 343 5202

IndustryMedical Instruments & Supplies
Full-time employees27

Key executives

NameTitlePayExercisedYear born
Mr. Robert BanksPresident, CEO & DirectorN/AN/AN/A
Ms. Judy F. Krandel C.F.A.Chief Financial OfficerN/AN/A1965
Brianne McGuireDirector of Brand & MarketingN/AN/AN/A
Vashone R. ThomasVice President of Quality, Regulatory, & Human ResourcesN/AN/AN/A
Mr. Daron G. EvansChief Executive Officer of Specialty Renal Products, Inc300.18kN/A1974
Mr. Greg LucasPresident of Aether Water SystemsN/AN/AN/A
Ms. Judy MazziniControllerN/AN/AN/A
Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Nephros, Inc. engages in development and sale of high performance water solutions to the medical and commercial markets in the United States. The company operates in two segments: Water Filtration and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also develops and sells medical device products for patients with renal disease, including a second generation hemodiafiltration system for the treatment of patients with end stage renal disease. In addition, it manufactures and sells water filters that improve the taste and odor of water, as well as reduce biofilm, bacteria, and scale build-up in downstream equipment under the Nephros and Nanoguard brands for the food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

Corporate governance

Nephros, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.